Lipigon Pharmaceuticals AB Financial Overview
Lipigon Pharmaceuticals AB's market cap is currently €446.55K. The company's EPS TTM is €-0.001102152; its P/E ratio is -0.85; Lipigon Pharmaceuticals AB is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
